ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

NBSE NeuBase Therapeutics Inc

0,3522
-0,0528 (-13,04%)
Vor Marktöffnung
Zuletzt aktualisiert: 14:46:44
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
NeuBase Therapeutics Inc NBSE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0528 -13,04% 0,3522 14:46:44
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,405
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202413:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05.4.202422:05GLOBENeuBase Therapeutics Announces Receipt of Notice from Nasdaq
07.3.202422:01EDGAR2Form 8-K - Current report
23.2.202422:01EDGAR2Form 8-K - Current report
26.1.202414:00EDGAR2Form 8-K - Current report
17.1.202412:15EDGAR2Form 8-K - Current report
28.12.202313:00EDGAR2Form 8-K - Current report
28.12.202312:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22.12.202312:15EDGAR2Form 8-K - Current report
27.11.202315:00GLOBEPsychemedics Corporation Appoints Daniella Mehalik as VP -..
09.11.202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202323:00EDGAR2Form 8-K - Current report
20.10.202313:30EDGAR2Form 8-K - Current report
18.10.202314:00EDGAR2Form 8-K - Current report
29.9.202322:10EDGAR2Form 8-K - Current report
21.9.202302:42EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
20.9.202323:28EDGAR2Form SC 13D/A - General statement of acquisition of..
18.9.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.9.202322:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18.9.202322:17EDGAR2Form 8-K - Current report
14.9.202312:03EDGAR2Form SC 13D/A - General statement of acquisition of..
11.9.202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202313:00GLOBENeuBase Therapeutics Issues Statement Regarding Filing By..
07.9.202323:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202316:00PRNUSSYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
31.8.202317:50EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14.8.202322:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202312:18EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11.8.202312:15EDGAR2Form DEF 14A - Other definitive proxy statements
10.8.202323:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04.8.202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202313:05EDGAR2Form 8-K - Current report
01.8.202322:45EDGAR2Form PRE 14A - Other preliminary proxy statements
31.7.202322:10EDGAR2Form 8-K - Current report
28.7.202312:03EDGAR2Form S-1 - General form for registration of securities under..
30.6.202322:21EDGAR2Form 8-K - Current report
30.6.202314:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30.6.202314:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Kürzlich von Ihnen besucht

Delayed Upgrade Clock